# Mangrove Therapeutics Inc. — Form D

Mangrove Therapeutics Inc. of SACRAMENTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-07-31. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-07-31
- Form: D
- Accession: 0002111089-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.5M
- Remaining: $2.5M
- Minimum investment: $25K
- Investors: 9
- Revenue range: No Revenues
- SEC file number: 021-592823

## Issuer

- Name: Mangrove Therapeutics Inc.
- CIK: 0002111089
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2108 N ST STE C, SACRAMENTO, CA, 95816
- Phone: (650) 485-3618

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Benjamin Zhiyi Chen | Related Person | Sacramento, CA |
| Alexander Simon Green | Related Person | Sacramento, CA |
| Jin Li | Related Person | Sacramento, CA |

## More

- [CIK 2111089 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2111089&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002111089-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.